Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
Tong‐Yuan Yang(Janssen (United States)), Vibha Jawa(Bristol-Myers Squibb (Germany)), Wibke Lembke, Maya Vinzing(Bayer (Germany)), LiNa Loo(Vertex Pharmaceuticals (United States)), John Kamerud(Pfizer (United States)), Uma Kavita(Spark Therapeutics (United States)), Kay‐Gunnar Stubenrauch(Roche Pharma AG (Germany)), Stephen DeWall, Manuela Braun(Bayer (Germany)), Xiaodong Fang(BGI Group (China)), Rakesh Kantilal Chandode(AstraZeneca (Sweden)), Lena Hofer(Spark Therapeutics (United States)), Edit Tarcsa(Massachusetts Academy of Math and Science at WPI), Fraser McBlane(Novartis (Switzerland)), Alison J. Johnson(Boehringer Ingelheim (United States)), Vijay Upreti(Amgen (United States)), Cindy Q. Xia(Takeda (United States)), Swati Gupta(AbbVie (United States))
Cited by 113
Related Papers
A global reference for human genetic variation
|Nature|2015|19.9k
The diploid genome sequence of an Asian individual
|Nature|2008|960
Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques
|Nature Biotechnology|2011|321
A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome
|Journal of Clinical Investigation|2019|190